Pfizer

While Pfizer isn't directly mentioned, the provided articles highlight key issues within the pharmaceutical landscape. One article notes a concerning decline in the development of new drugs to combat superbugs, with large pharma companies reducing their projects by 35% in the last five years. This underscores a potential crisis in addressing drug-resistant infections. Another article focuses on executive compensation within the industry, specifically highlighting AstraZeneca's CEO's substantial pay rise. Finally, the launch of 'TrumpRx', a website aimed at providing discounted prescription drugs, signals ongoing efforts to address drug affordability concerns in the US. These developments collectively emphasize the challenges and complexities surrounding drug development, accessibility, and cost within the pharmaceutical sector.